Effect of Severe Limb Purpura Following the Administration of COVID-19Vaccination on a Diabetic Foot Requiring Amputation: A Case Report
10.14193/jkfas.2022.26.1.48
- Author:
Byung Ho KIM
1
;
Jin Soo SUH
;
Sun Hee CHANG
;
Jun Young CHOI
Author Information
1. Departments of Orthopaedic Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
- Publication Type:Case Report
- From:Journal of Korean Foot and Ankle Society
2022;26(1):48-53
- CountryRepublic of Korea
- Language:English
-
Abstract:
The current SARS-CoV‑2 coronavirus disease 2019 (COVID-19) pandemic has been a particular challenge for diabetes patients. Since these patients are at a higher risk of COVID-19, they have been prioritized for vaccination. In this report, we describe the case of a patient scheduled for diabetic foot amputation who received the first dose of ChAdOx1 nCov-19 vaccine and subsequently developed severe purpura in his genitalia and both of his hands and feet, accompanied by acute renal failure. The operation had to be postponed as severe limb purpura appeared just before the operation. With adequate management for acute renal failure and topical steroid application for the severe purpura lesions, a successful outcome could be obtained after the delayed first ray amputation. We recommend that COVID-19 vaccination should be carefully administered in patients with a diabetic foot requiring amputation.
